Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers

European Urology

Volumn 56, Issue 3, 2009, Pages 542-

  Dmochowski, Roger ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TOLTERODINE; BENZHYDRYL DERIVATIVE; CRESOL; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE;

BLADDER FUNCTION; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MONOTHERAPY; NOTE; OVERACTIVE BLADDER; PRIORITY JOURNAL; RESIDUAL URINE; RESIDUAL VOLUME; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINE RETENTION; DRUG COMBINATION; PROSTATISM;

ADRENERGIC ALPHA-ANTAGONISTS; BENZHYDRYL COMPOUNDS; CRESOLS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; PROSTATISM; URINARY BLADDER, OVERACTIVE;

EID: 67651055242     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.11.027     Document Type: Note

References (3)

1. Chapple C., Herschorn S., Abrams P., Sun F., Brodsky M., and Guan Z. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with α-blockers. Eur Urol 56 (2009) 534-543
2. Kaplan S.A., Roehrborn C.G., Rovner E.S., et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 296 (2006) 2319-2328
3. Blake-James B.T., Rashidian A., Ikeda Y., and Emberton M. The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. BJU Int 99 (2007) 85-96